Completed Access to Information Requests

Transitional Period

Federal departments are moving their web content to Canada.ca. As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at open-ouvert@tbs-sct.gc.ca .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 251 record(s)

Req # A-2018-001619

Adverse Reaction Report (AER). Report numbers: E2B_02094722, E2B_02094712.

Organization: Health Canada

138 page(s)
April 2019

Req # A-2018-001646

Records regarding the discussion concerning the legalization of cannabis edibles from September 1, 2018 to the February 14, 2019.

Organization: Health Canada

22 page(s)
April 2019

Req # A-2013-000021

Bureau of Pharmaceutical Assessment Reviewer's report for: Fentanyl, Citrate Injection SDZ, Drug Identification Number (DIN) # 02384124 / Naxloxone Hydrochloride Injection SDZ, DIN 02382601 / Furosemide Injection SDZ, DIN 02382539.

Organization: Health Canada

359 page(s)
April 2019

Req # A-2014-000008

All documents within Health Canada about the abortion drug/pill RU-486, also known as Mifepristone, from November 1st, 2013 to April 14th, 2014.

Organization: Health Canada

375 page(s)
April 2019

Req # A-2014-000022

Submission data and correspondence related to authorization (issuing letter of No Objection) for Cibus 5715 Canola.

Organization: Health Canada

363 page(s)
April 2019

Req # A-2014-000106

All documents related to the group of pesticides called Neonicotinoids on whether or not that group of pesticides should be banned. Time period from August 16, 2013 to September 5, 2014.

Organization: Health Canada

335 page(s)
April 2019

Req # A-2014-000225

Copies of Module 1-5 for the submission related to Hospira's DOCETAXEL FOR INJECTION, 20MG/2ML SINGLE-USE VIAL, 80MG/8ML MULTIDOSE VIAL, 160MG/16ML MULTIDOSE VIAL, 02361957 as well as any pre-submission meeting minutes.

Organization: Health Canada

193 page(s)
April 2019

Req # A-2015-000020

Wind Turbine Noise and Health Study. All records between Health Canada (HC) and MG for this contract. This includes all microphone, microbarometer, vibration, weather station, and turbine operational data.

Organization: Health Canada

312 page(s)
April 2019

Req # A-2015-000052

Briefing materials, question period notes, memoranda to the Assistant Deputy Minister and Minister dealing with E-cigarettes for the period 2014-05-05 to 2015-05-05.

Organization: Health Canada

72 page(s)
April 2019

Req # A-2015-000219

From January 1, 2015 to July 31, 2015, all documents relating to the changes to homeopathic cough, cold and flu products for children 12 and under that were introduced by Health Canada on July 31, 2015.

Organization: Health Canada

266 page(s)
April 2019